[

covishield

]
PAGE 2
Union health minister Mansukh Mandaviya said that India has administered 470 million doses of Covid-19 vaccine so far.(HT File Photo)

Covishield output to be increased to 120 million, Covaxin to 58 million: Govt

By hindustantimes.com | Written by Amit Chaturvedi, Hindustan Times, New Delhi
PUBLISHED ON AUG 03, 2021 05:33 PM IST
The government expects that by October-November, four more Indian pharmaceutical companies will start production of indigenous vaccines that will help meet the domestic demand, Union health minister Mansukh Mandaviya said.
SII, which is the largest vaccine manufacturer across the globe, has been producing the United Kingdom (UK)-based AstraZeneca vaccine under the brand name of ‘Covishield’ in India.(AFP file photo)
SII, which is the largest vaccine manufacturer across the globe, has been producing the United Kingdom (UK)-based AstraZeneca vaccine under the brand name of ‘Covishield’ in India.(AFP file photo)

Serum Institute joins hands with CII to accelerate vaccination in rural areas

By hindustantimes.com | Written by Harshit Sabarwal | Edited by Poulomi Ghosh, New Delhi
UPDATED ON JUL 30, 2021 06:00 PM IST
Speaking on Friday’s development, SII’s chief executive officer (CEO) Adar Poonawalla said the partnership with the Confederation of Indian Industry “will be a good way to close the gaps” as there is plenty of supply of Covishield doses available for distribution.
The first ever trial of a mixed dose of Covishield and Covaxin will take place in India.
The first ever trial of a mixed dose of Covishield and Covaxin will take place in India.

Can Covishield and Covaxin be mixed? What we know about this

By hindustantimes.com | Written by Poulomi Ghosh
UPDATED ON JUL 30, 2021 04:20 PM IST
Covaxin and Covishield have been developed differently. Theoretically, there is no problem in mixing them, experts told earlier. But the issue needs more research the first of which will now be conducted by Christian Medical College in Vellore
Private hospitals are charging <span class='webrupee'>₹</span>250 for one dose of both Covishield and Covaxin, which includes <span class='webrupee'>₹</span>100 administration charge.(PTI)
Private hospitals are charging 250 for one dose of both Covishield and Covaxin, which includes 100 administration charge.(PTI)

Expert panel recommends trials on mixing Covid-19 vaccines - Covaxin, Covishield

ANI |
UPDATED ON JUL 30, 2021 07:41 AM IST
The purpose behind the study of mixing Covid-19 vaccines is to see whether a person can be given two different vaccine shots of Covishield and Covaxin to complete the inoculation course.
According to the study, the Covishield vaccine reduced fresh infections by 93% and deaths by 98%.(AFP)
According to the study, the Covishield vaccine reduced fresh infections by 93% and deaths by 98%.(AFP)

Covishield vaccine reduced new Covid-19 cases by 93%, deaths by 98%: Centre

Written by Srivatsan K C | Edited by Avik Roy, Hindustan Times, New Delhi
PUBLISHED ON JUL 27, 2021 11:31 PM IST
The study was largely conducted on healthy males with few comorbid illnesses. However, children and the elderly were not included in the study
The Tamil Nadu government received 8,60,000 coronavirus vaccine doses on Tuesday.
The Tamil Nadu government received 8,60,000 coronavirus vaccine doses on Tuesday.

TN gets over 8.5 lakh Covid-19 vaccines; test positivity rate up in few district

By hindustantimes.com | Edited by Sharangee Dutta, Hindustan Times, New Delhi
PUBLISHED ON JUL 21, 2021 04:05 PM IST
  • The Centre on Tuesday sent additional 5 lakh doses of Covishield vaccines besides the 3,60,000 doses sent from its central stock in order to meet the state’s demands.
Covishield is now recognised in 16 European countries. Out of them 13 are EU members.
Covishield is now recognised in 16 European countries. Out of them 13 are EU members.

'Good news,' says Poonawalla as Covishield recognised by 16 European countries

By hindustantimes.com | Written by Poulomi Ghosh
PUBLISHED ON JUL 17, 2021 09:06 PM IST
France on Saturday became the 16th European country to recognise Covishield as a valid vaccine against Covid-19 for international travellers.
More than three years after coming to power in Tripura following the defeat of the two decades old Marxist government, the ruling Bharatiya Janata Party (BJP) and Indigenous Peoples Front of Tripura (IPFT) coalition government is planning to induct new faces in the state cabinet
More than three years after coming to power in Tripura following the defeat of the two decades old Marxist government, the ruling Bharatiya Janata Party (BJP) and Indigenous Peoples Front of Tripura (IPFT) coalition government is planning to induct new faces in the state cabinet

News updates from HT: Tripura cabinet expansion 'likely' on the cards

By hindustantimes.com, Hindustan Times, New Delhi
PUBLISHED ON JUL 17, 2021 05:01 PM IST
  • Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
A vial of the Covishield Covid-19 vaccine, developed by Oxford-Astrazeneca Plc. and manufactured by Serum Institute of India Ltd., at a vaccination center set up at a school in Dharamshala, Himachal Pradesh. (Bloomberg)
A vial of the Covishield Covid-19 vaccine, developed by Oxford-Astrazeneca Plc. and manufactured by Serum Institute of India Ltd., at a vaccination center set up at a school in Dharamshala, Himachal Pradesh. (Bloomberg)

Uncertainty persists over EMA approval for SII’s Covishield

By HT Correspondent, Hindustan Times, New Delhi
UPDATED ON JUL 17, 2021 04:15 AM IST
An industry executive aware with the matter, however, contended that the certification is following a different route since Serum Institute of India – the maker of Covishield – will not seek to sell the vaccine.
Know all about the latest news and other news updates from Hindustan Times.
Know all about the latest news and other news updates from Hindustan Times.

News updates from HT: Arvind Kejriwal in Goa today with eyes on Assembly polls

By hindustantimes.com, Hindustan Times, New Delhi
UPDATED ON JUL 13, 2021 09:45 AM IST
  • Here are today’s top news, analysis and opinion at 9am. Know all about the latest news and other news updates from Hindustan Times.
A medical staff prepares a jab of the Covishield, AstraZeneca-Oxford's Covid-19 coronavirus vaccine. (AFP)
A medical staff prepares a jab of the Covishield, AstraZeneca-Oxford's Covid-19 coronavirus vaccine. (AFP)

Days after Centre's statement, Delhi and other states claim vaccine shortage

By hindustantimes.com | Written by Joydeep Bose
PUBLISHED ON JUL 13, 2021 08:13 AM IST
Government data shows a drop in average daily inoculation since June 21, when the Covid-19 vaccine drive was opened to everyone above 18 years of age.
People walk on the street in the center of Brussels. (AP Photo)
People walk on the street in the center of Brussels. (AP Photo)

Belgium recognises Covishield vaccines, allows students to travel to country

By hindustantimes.com | Written by Shankhyaneel Sarkar | Edited by Poulomi Ghosh, Hindustan Times, New Delhi
PUBLISHED ON JUL 09, 2021 09:40 PM IST
  • The Belgian embassy in India announced that it has recognised Covishield via a tweet. The Netherlands approved Covishield earlier this week for travellers.
Several European countries have recognised Covishield for travel purpose. (Bloomberg)
Several European countries have recognised Covishield for travel purpose. (Bloomberg)

Covishield and Covaxin: List of European countries which recognise these

By hindustantimes.com | Written by Poulomi Ghosh
PUBLISHED ON JUL 04, 2021 07:50 PM IST
Estonia accepts both Covishield and Covaxin as valid against Covid-19 as far as travellers are concerned.
After two doses, the neutralising antibodies could not be detected in 16.1% of the samples, the study found. (Bloomberg)
After two doses, the neutralising antibodies could not be detected in 16.1% of the samples, the study found. (Bloomberg)

Delta variant: No antibodies in 16% after second dose of Covishield, says study

By Anonna Dutt, New Delhi, Hindustan Times
UPDATED ON JUL 04, 2021 03:30 AM IST
The titres of the neutralising antibodies – that specifically target the Sars-CoV-2 virus and kill it or prevent it from entering human cells – were also lower against the Delta variant as compared to the B1 variant that led to the first wave of infections in India.
The study only evaluated the immune response of the Covishield vaccine among various groups of partially and fully vaccinated people. (Bloomberg)
The study only evaluated the immune response of the Covishield vaccine among various groups of partially and fully vaccinated people. (Bloomberg)

Who are 'highly protected' against Delta variant of Covid? ICMR study reveals

By hindustantimes.com | Written by Poulomi Ghosh
PUBLISHED ON JUL 03, 2021 10:51 PM IST
Covid recovered with even one dose of the vaccine have higher protection against Delta variant than those who have never been infected but have got vaccinated.
A healthcare worker fills a syringe with a dose of Covid-19 vaccine.(REUTERS)
A healthcare worker fills a syringe with a dose of Covid-19 vaccine.(REUTERS)

'Treat vaccinated Indians on par with those inoculated in EU states': India

By Rezaul H Laskar, New Delhi
UPDATED ON JUL 02, 2021 09:20 PM IST
  • The remarks by external affairs ministry spokesperson Arindam Bagchi came at a weekly news briefing on Friday.
European countries are yet to lift travel restrictions for Indians.(Vipin Kumar/HT Photo)
European countries are yet to lift travel restrictions for Indians.(Vipin Kumar/HT Photo)

Can Indians now travel to European countries? All you need to know

By hindustantimes.com | Written by Poulomi Ghosh
PUBLISHED ON JUL 01, 2021 12:54 PM IST
The Embassy of Switzerland has recently lifted travel restrictions and Indians fully vaccinated with Covishield can travel to Switzerland, but the country does not approve Covaxin.
Covishield will receive EMA approval in a month and nothing will be hindered, Serum Institute CEO Adar Poonawalla has said. (REUTERS)
Covishield will receive EMA approval in a month and nothing will be hindered, Serum Institute CEO Adar Poonawalla has said. (REUTERS)

'No controversy': Adar Poonawalla on Covishield being excluded from EU pass

By hindustantimes.com | Written by Poulomi Ghosh
PUBLISHED ON JUL 01, 2021 11:24 AM IST
Adar Poonwalla said Covishield will receive approval from the European Medicines Agency in a month.
Covishield vaccine vials during a vaccination drive, at Navyug School, Mandir Marg, in New Delhi, India, on Tuesday, June 29, 2021. (Photo by Sanchit Khanna/ Hindustan Times)
Covishield vaccine vials during a vaccination drive, at Navyug School, Mandir Marg, in New Delhi, India, on Tuesday, June 29, 2021. (Photo by Sanchit Khanna/ Hindustan Times)

SII produces 90 million doses a month, says CEO amid reports of vaccine shortage

By hindustantimes.com | Written by Joydeep Bose
PUBLISHED ON JUL 01, 2021 06:23 AM IST
Covid-19 vaccine shortage in India: Several states and Union territories, including Odisha, Punjab, and Delhi, have flagged a shortage of Covid-19 vaccines earlier this week amid the inoculation drive.
S Jaishankar with EU official Josep Borrell Fontelles (twitter.com/DrSJaishankar)
S Jaishankar with EU official Josep Borrell Fontelles (twitter.com/DrSJaishankar)

Green Pass: Jaishankar discusses Covishield with top EU official

By hindustantimes.com | Written by Karan Manral | Edited by Amit Chaturvedi, New Delhi
UPDATED ON JUN 30, 2021 08:44 AM IST
From July 1, a 'Green Pass' will be needed to travel freely within the European Union (EU). Covishield is not among the four vaccines cleared by the European Medicines Agency (EMA).
The order does not apply to private facilities. (Photo by Sunil Ghosh / Hindustan Times)
The order does not apply to private facilities. (Photo by Sunil Ghosh / Hindustan Times)

No Covid vaccination at government centres in Noida on June 30

PTI | , Noida
PUBLISHED ON JUN 29, 2021 10:35 PM IST
  • The decision to cancel all vaccinations, including Covishield and Covaxin, has been taken due to "unavoidable" reasons, Chief Medical Officer Dr. Deepak Ohri said.
Those vaccinated with Covishield may not be eligible for the EU ‘Green Pass’ that will be available to use from July 1.(AFP)
Those vaccinated with Covishield may not be eligible for the EU ‘Green Pass’ that will be available to use from July 1.(AFP)

EMA had not received Covishield approval request for 'Green Pass': EU

By hindustantimes.com | Edited by Kunal Gaurav, Hindustan Times, New Delhi
UPDATED ON JUN 29, 2021 03:26 PM IST
  • The official clarified that the EU Digital COVID Certificate is meant to facilitate restriction-free movement with the member states and is not a pre-condition to travel.
The Serum Institute of India is approaching the EMA for approval of its Covid-19 vaccine, Covishield, for the European Union’s Green Pass. (File Photo)
The Serum Institute of India is approaching the EMA for approval of its Covid-19 vaccine, Covishield, for the European Union’s Green Pass. (File Photo)

EU’s ‘green pass’ for Covishield: What is the document all about

By hindustantimes.com | Written by Meenakshi Ray, New Delhi
PUBLISHED ON JUN 29, 2021 05:28 AM IST
The Serum Institute of India is approaching the European Medicines Agency for approval of its Covid-19 vaccine, Covishield, for the European Union’s Green Pass.
The Covishield vaccine “does not currently have a marketing authorisation” in Europe and the matter would be considered when an application is received for it, the EMA said.(AFP )
The Covishield vaccine “does not currently have a marketing authorisation” in Europe and the matter would be considered when an application is received for it, the EMA said.(AFP )

SII says working on Covishield EU pass

By HT Correspondent, Hindustan Times, New Delhi
UPDATED ON JUN 29, 2021 04:41 AM IST
Indian officials said it was “perplexing” that the list includes Vaxzevria, the AstraZeneca vaccine produced and marketed in the UK and other sites around Europe, but not Covishield, the version manufactured and distributed in India, though they are similar if not identical.
Soni Razdan is unhappy about Covishield being excluded from the eligibility list for the EU’s Green Pass.
Soni Razdan is unhappy about Covishield being excluded from the eligibility list for the EU’s Green Pass.

Soni reacts to Covishield’s exclusion from EU’s Green Pass eligibility list

PUBLISHED ON JUN 28, 2021 09:53 AM IST
Soni Razdan is unhappy about Covishield, a version of the AstraZeneca Covid-19 vaccine manufactured by Serum Institute of India and approved by WHO, being excluded from the eligibility list for the EU’s Green Pass.
A majority of people in India have received Covishield, manufactured locally by Pune-based Serum Institute of India.(Vipin Kumar /HT file photo)
A majority of people in India have received Covishield, manufactured locally by Pune-based Serum Institute of India.(Vipin Kumar /HT file photo)

Covishield may not be eligible for ‘vaccine passport’ by the EU

By HT Correspondent, Hindustan Times, New Delhi
UPDATED ON JUN 28, 2021 05:48 AM IST
The European Union had earlier said that member states can issue the certificates regardless of the type of Covid-19 vaccine, but the technical specifications indicate that the pass will be limited to “vaccines that have received EU-wide marketing authorization”.
Covishield, a version of the AstraZeneca Covid vaccine, has not been approved by the EMA for the European market.(AP)
Covishield, a version of the AstraZeneca Covid vaccine, has not been approved by the EMA for the European market.(AP)

Covishield excluded from new EU Covid 'Green Pass' eligibility list

By hindustantimes.com | Edited by Kunal Gaurav, Hindustan Times, New Delhi
PUBLISHED ON JUN 27, 2021 07:53 PM IST
  • Covishield, a version of the AstraZeneca Covid vaccine manufactured by Pune-based Serum Institute of India (SII), has not been approved by the EMA for the European market.
As many as 32,17,60,077 people have been vaccinated against Covid-19 in India as of now.(HT file photo)
As many as 32,17,60,077 people have been vaccinated against Covid-19 in India as of now.(HT file photo)

Covid-19: How will you be compensated if things go south after vaccination?

Written by Prashasti Singh | Edited by Meenakshi Ray, Hindustan Times, New Delhi
PUBLISHED ON JUN 27, 2021 10:49 AM IST
Serum Institute of India's (SII) Covishield, Bharat Biotech’s Covaxin and Russia’s Sputnik V are the three vaccines which have been cleared by the Indian government.
A health worker prepares a dose of the Covishield vaccine, developed by Oxford-AstraZeneca Plc. and manufactured by Serum Institute of India Ltd., for a student, who has a place to study abroad, at a Covid-19 vaccination center set up in a school in New Delhi India, on Thursday, June 24, 2021. (Bloomberg)
A health worker prepares a dose of the Covishield vaccine, developed by Oxford-AstraZeneca Plc. and manufactured by Serum Institute of India Ltd., for a student, who has a place to study abroad, at a Covid-19 vaccination center set up in a school in New Delhi India, on Thursday, June 24, 2021. (Bloomberg)

India administered over six million Covid-19 vaccine doses in a day

By hindustantimes.com | Edited by Joydeep Bose
PUBLISHED ON JUN 25, 2021 10:01 AM IST
Daily recoveries continue to outnumber the single-day spike for the 43rd consecutive day, the central government said. The recovery rate has increased to 96.66% while the weekly positivity rate remains below 5% and is currently at 3%.
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved